Close
Back to VRDN Stock Lookup
Pages: 1 2 3 4 5 6 »» Last Page

(VRDN) –

Apr 16, 2024 04:06 PM Form 8-K Viridian Therapeutics, For: Apr 10
Apr 10, 2024 02:38 PM Viridian Therapeutics (VRDN) May 15 puts active
Apr 4, 2024 04:01 PM Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 1, 2024 06:39 PM Form SC 13D/A Viridian Therapeutics, Filed by: Fairmount Funds Management LLC
Apr 1, 2024 06:33 PM Form 4 Viridian Therapeutics, For: Mar 28 Filed by: Fairmount Funds Management LLC
Mar 21, 2024 07:32 AM Viridian Therapeutic (VRDN) PT Lowered to $25 at B.Riley
Mar 6, 2024 04:01 PM Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar 5, 2024 08:00 AM Viridian Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
Feb 29, 2024 05:33 AM Viridian Therapeutic (VRDN) PT Lowered to $37 at Wells Fargo
Feb 28, 2024 04:15 PM Form S-8 Viridian Therapeutics,
Feb 28, 2024 02:34 AM Viridian Therapeutic (VRDN) PT Lowered to $37 at JMP Securities
Feb 28, 2024 02:14 AM Viridian Therapeutics, Inc. (VRDN) Misses Q4 EPS by 37c
Feb 27, 2024 04:37 PM Form 10-K Viridian Therapeutics, For: Dec 31
Feb 27, 2024 04:09 PM Form 8-K Viridian Therapeutics, For: Feb 27
Feb 27, 2024 04:01 PM Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 16, 2024 08:01 AM Viridian Therapeutics (VRDN) Appoints Jennifer Tousignant as Chief Legal Officer
Feb 16, 2024 08:00 AM Viridian Therapeutics Appoints Jennifer Tousignant as Chief Legal Officer
Feb 14, 2024 08:29 PM Form SC 13G/A Viridian Therapeutics, Filed by: Venrock Healthcare Capital Partners III, L.P.
Feb 14, 2024 04:09 PM Form SC 13G/A Viridian Therapeutics, Filed by: Paradigm Biocapital Advisors LP
Feb 14, 2024 04:06 PM Form SC 13G/A Viridian Therapeutics, Filed by: COMMODORE CAPITAL LP
Feb 14, 2024 04:06 PM Form 4 Viridian Therapeutics, For: Feb 12 Filed by: Tousignant Jennifer
Feb 14, 2024 04:06 PM Form 3 Viridian Therapeutics, For: Feb 12 Filed by: Tousignant Jennifer
Feb 14, 2024 09:23 AM Form SC 13G/A Viridian Therapeutics, Filed by: BIOTECHNOLOGY VALUE FUND L P
Feb 14, 2024 09:01 AM Form SC 13G/A Viridian Therapeutics, Filed by: Deep Track Capital, LP
Feb 13, 2024 06:15 PM Form SC 13G/A Viridian Therapeutics, Filed by: VANGUARD GROUP INC
Feb 7, 2024 04:01 PM Form 4 Viridian Therapeutics, For: Feb 05 Filed by: Ciulla Thomas
Feb 6, 2024 04:01 PM Viridian Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jan 29, 2024 04:54 PM Form SC 13G Viridian Therapeutics, Filed by: PERCEPTIVE ADVISORS LLC
Jan 29, 2024 03:27 PM Form SC 13G/A Viridian Therapeutics, Filed by: BlackRock Inc.
Jan 24, 2024 06:45 PM Form 4 Viridian Therapeutics, For: Jan 22 Filed by: Fairmount Funds Management LLC
Jan 24, 2024 05:13 PM Form SC 13D/A Viridian Therapeutics, Filed by: Fairmount Funds Management LLC
Jan 24, 2024 08:14 AM Form SC 13G Viridian Therapeutics, Filed by: STATE STREET CORP
Jan 22, 2024 07:12 AM Viridian Therapeutic (VRDN) PT Lowered to $39 at Wedbush
Jan 19, 2024 05:23 PM Form 8-K Viridian Therapeutics, For: Jan 17
Jan 19, 2024 04:33 PM Form 424B5 Viridian Therapeutics,
Jan 18, 2024 05:07 AM Viridian Therapeutics (VRDN) Prices 7.14M Share Offering at $21/sh
Jan 17, 2024 10:00 PM Viridian Therapeutics Announces Pricing of Public Offering of Shares of Common Stock
Jan 17, 2024 04:04 PM Form 424B5 Viridian Therapeutics,
Jan 17, 2024 04:01 PM Viridian Therapeutics (VRDN) Announces Proposed Common and Preferred Stock Offering
Jan 17, 2024 04:01 PM Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
Jan 12, 2024 04:32 PM Form 3 Viridian Therapeutics, For: Jan 03 Filed by: Ciulla Thomas
Jan 10, 2024 08:53 AM Form SC 13G Viridian Therapeutics, Filed by: FMR LLC
Jan 8, 2024 08:13 AM Viridian Therapeutics (VRDN) to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference
Jan 8, 2024 08:08 AM Form 8-K Viridian Therapeutics, For: Jan 03
Jan 8, 2024 08:00 AM Viridian Therapeutics to Present Key 2024 Corporate Priorities at J.P. Morgan Healthcare Conference
Jan 4, 2024 08:00 AM Viridian Therapeutics to Webcast Presentation at the 42nd Annual J.P. Morgan Healthcare Conference
Dec 19, 2023 05:28 AM Viridian Therapeutic (VRDN) PT Raised to $36 at Oppenheimer
Dec 18, 2023 11:46 AM Form 144 Viridian Therapeutics, Filed by: Meisner Lara
Dec 18, 2023 08:16 AM Form 8-K Viridian Therapeutics, For: Dec 15
Dec 18, 2023 07:02 AM Viridian Therapeutics (VRDN) Reports Positive Clinical Data in Healthy Volunteer Study and Selects VRDN-003 as Potential Best-in-Class Subcutaneous anti-IGF-1R Program
Pages: 1 2 3 4 5 6 »» Last Page

Back to VRDN Stock Lookup